EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects

Megan Bonsor, Orchid Ammar, Sigrid Schnoegl, Erich E Wanker iD, Eduardo Silva Ramos iD

PROTEOMICS · 2024

DOI: 10.1002/pmic.202300114 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PROTEOMICS, 2024. Verfasst von Megan Bonsor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroproteomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany. Hauptthemen laut MEDLINE: Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Huntington's Disease Society of America, Berman-Topper Family HD Career Development Fellowship, CHDI Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, nine polyglutamine (polyQ) expansion diseases are known. They include spinocerebellar ataxias (SCA1, 2, 3, 6, 7, 17), spinal and bulbar muscular atrophy (SBMA), dentatorubral‐pallidoluysian atrophy (DRPLA), and Huntington's disease (HD). At the root of these neurodegenerative diseases are trinucleotide repeat mutations in coding regions of different genes, which lead to the production of proteins with elongated polyQ tracts. While the causative proteins differ in structure and molecular mass, the expanded polyQ domains drive pathogenesis in all these diseases. PolyQ tracts mediate the association of proteins leading to the formation of protein complexes involved in gene expression regulation, RNA processing, membrane trafficking, and signal transduction. In this review, we discuss commonalities and differences among the nine polyQ proteins focusing on their structure and function as well as the pathological features of the respective diseases. We present insights from AlphaFold‐predicted structural models and discuss the biological roles of polyQ‐containing proteins. Lastly, we explore reported protein–protein interaction networks to highlight shared protein interactions and their potential relevance in disease development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesHumansNeurodegenerative DiseasesAnimalsProtein Interaction MapsTrinucleotide Repeat Expansion

Stichwörter der Autor:innen

interactomepolyQ diseasepolyQ expansionprotein networksprotein structure

Substanzen

polyglutaminePeptides

Autor:innen und Institutionen

  • Department of Neuroproteomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany.

ORCID-Profile: Erich E Wanker, Eduardo Silva Ramos

Förderung

  • Huntington's Disease Society of America
  • Berman-Topper Family HD Career Development Fellowship
  • CHDI Foundation

Zitieren

APA

Bonsor, M., Ammar, O., Schnoegl, S., Wanker, E. E., & Silva Ramos, E. (2024). Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects. PROTEOMICS. https://doi.org/10.1002/pmic.202300114

Vancouver

Bonsor M, Ammar O, Schnoegl S, Wanker EE, Silva Ramos E. Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects. PROTEOMICS. 2024. doi:10.1002/pmic.202300114

BibTeX
@article{Bonsor2024,
  author = {Bonsor, Megan and Ammar, Orchid and Schnoegl, Sigrid and Wanker, Erich E and Silva Ramos, Eduardo},
  title = {Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects},
  journal = {PROTEOMICS},
  year = {2024},
  doi = {10.1002/pmic.202300114}
}
Kostenlos starten →